Analystreport

Cellectis SA (NASDAQ: CLLS) had its "sell" rating re-affirmed by analysts at Goldman Sachs Group Inc. They now have a $11.00 price target on the stock, down previously from $15.00.

Cellectis S.A. - American Depositary Shares  (CLLS) 
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors